Repurposed drugs

Niclosamide, an FDA-approved antihelminthic drug traditionally used to treat tapeworm infections, has shown promising preclinical activity against prostate cancer, particularly castration-resistant prostate cancer (CRPC). Its potential as an anticancer agent…

Ivermectin, an antiparasitic drug, has shown potential anticancer effects in preclinical studies for prostate cancer, but evidence in humans is limited and inconclusive. Here's a concise overview based on available…

Fenbendazole, a benzimidazole anthelmintic primarily used to treat parasitic infections in animals, has gained attention for its potential anticancer properties, including in prostate cancer. Below is a summary of the…